QuickView for aphidicolin (compound)

1. HeLa cells after G0-G1 / G1-S arrest release with CDK4/6 shRNA and IL-1a treated
2. Embryonic stem H1 cells treated with aphidicolin alone or in combination with AZD7762
3. Lymphocytes transformed with Epstein-Barr virus form fragile X patients treated with aphidicolin

1. Effect of Aphidicolin, a Reversible Inhibitor of Eukaryotic Nuclear DNA Replication, on the Producti…
2. Nuclear localization of endothelial nitric oxide synthase and nitric oxide production attenuates aph…
3. Stability of cytoplasmic nanoviscosity during cell cycle of HeLa cells synchronized with Aphidicolin…
4. Semisynthesis of new aphidicolin derivatives with high activity against Trypanosoma cruzi.
5. Low Replicative Stress Triggers Cell-Type Specific Inheritable Advanced Replication Timing.

There were no clinical trials for aphidicolin